Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H21NO2 |
| Molecular Weight | 271.3541 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCC[C@@H](OC1=CC=CC=C1OC)C2=CC=CC=C2
InChI
InChIKey=ITJNARMNRKSWTA-OAHLLOKOSA-N
InChI=1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3/t15-/m1/s1
| Molecular Formula | C17H21NO2 |
| Molecular Weight | 271.3541 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16871320
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16871320
(R)-nisoxetine, an enantiomer of nisoxetine, is the potent and selective norepinephrine transporter (NET) inhibitor. Racemic nisoxetine doesn’t have any clinical application but had been researched as an antidepressant and its activity for NET resides mainly in the R-isomer.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16871320 |
0.46 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:39:19 GMT 2025
by
admin
on
Mon Mar 31 20:39:19 GMT 2025
|
| Record UNII |
ARR0KQW356
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
112066-67-8
Created by
admin on Mon Mar 31 20:39:19 GMT 2025 , Edited by admin on Mon Mar 31 20:39:19 GMT 2025
|
PRIMARY | |||
|
10107248
Created by
admin on Mon Mar 31 20:39:19 GMT 2025 , Edited by admin on Mon Mar 31 20:39:19 GMT 2025
|
PRIMARY | |||
|
ARR0KQW356
Created by
admin on Mon Mar 31 20:39:19 GMT 2025 , Edited by admin on Mon Mar 31 20:39:19 GMT 2025
|
PRIMARY |